Center for Scientific Review; Notice of Closed Meetings, 13301 [2022-04984]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–04980 Filed 3–8–22; 8:45 am]
inadvertently omitted the weblink
where the implementation plan is
located and can be found at https://
www.hhs.gov/vaccines/vaccinesnational-strategic-plan/vaccinesfederal-implementation-plan/
index.html#:∼:text=The%20Vaccines
%20Federal%20Implementation
%20Plan%20outlines%20specific
%20actions%20that%20federal,
National%20Strategic%20Plan
%202021%2D2025.&text=The
%20public%20comment%20period
%20for,2%2C%202022%20at%209
%20a.m.
Dated: March 2, 2022.
David Kim,
Director, Division of Vaccines, Office of the
Assistant Secretary for Health.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–04937 Filed 3–8–22; 8:45 am]
BILLING CODE 4150–44–P
Vaccines Federal Implementation Plan,
Request for Comments; Correction
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice; correction.
AGENCY:
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
The Office of the Assistant
Secretary for Health published a
document in the Federal Register of
March 2, 2022, announcing the request
for comments for the Vaccines Federal
Implementation Plan. The document
includes a weblink where the Vaccines
Federal Implementation Plan can be
found: https://www.hhs.gov/vaccines/
vaccines-national-strategic-plan/
vaccines-federal-implementation-plan/
index.html#:∼:text=The%20Vaccines
%20Federal%20Implementation
%20Plan%20outlines%20specific
%20actions%20that%20federal,
National%20Strategic%20Plan
%202021%2D2025.&text=The
%20public%20comment%20period
%20for,2%2C%202022%20at%209
%20a.m.
SUMMARY:
Dr.
David Kim, Director, Division of
Vaccines, U.S. Department of Health
and Human Services, Office of the
Assistant Secretary for Health, Room
L616, Switzer Building, 330 C St. SW,
Washington, DC 20024. Phone: 202–
795–7697; Email: nvp.rfi@hhs.gov.
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Correction
In the Federal Register of March 2,
2022, in FR Doc. 2022–04327, on page
11724, in the second column, correct
the subject line Meeting of the Vaccines
Federal Implementation Plan to read,
‘‘Vaccines Federal Implementation Plan,
Request for Comments’’. We also
VerDate Sep<11>2014
17:44 Mar 08, 2022
Jkt 256001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodegeneration and Drug
Discovery.
Date: April 5, 2022.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christine Jean DiDonato,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1014J,
Bethesda, MD 20892, (301) 435–1042,
didonatocj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
International and Cooperative Projects for
Global Emerging Leaders Award.
Date: April 6, 2022.
Time: 9:30 a.m. to 6:00 p.m.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
13301
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Micro Physiological Systems and
Implanted Devices.
Date: April 6, 2022.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert C. Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, (301) 435–
3009, elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Transplantation and Autoimmunity.
Date: April 6, 2022.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, (301) 443–
5779, prasads@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 4, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–04984 Filed 3–8–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 87, Number 46 (Wednesday, March 9, 2022)]
[Notices]
[Page 13301]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurodegeneration and Drug Discovery.
Date: April 5, 2022.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christine Jean DiDonato, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1014J, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: International and Cooperative Projects for Global
Emerging Leaders Award.
Date: April 6, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics: Micro Physiological Systems and Implanted
Devices.
Date: April 6, 2022.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert C. Elliott, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892, (301) 435-3009, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Transplantation and Autoimmunity.
Date: April 6, 2022.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, (301) 443-5779, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 4, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04984 Filed 3-8-22; 8:45 am]
BILLING CODE 4140-01-P
